94185 ā
Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms; Oxygen atoms attached in positions 2 and 6, e.g. glutarimide
N/O-LINKED DEGRONS AND DEGRONIMERS FOR PROTEIN DEGRADATION
#2MOLECULAR GLUE COMPOUND BASED ON CEREBLON PROTEIN DESIGN AND USE THEREOF
#3HYDANTOIN CONTAINING DEOXYURIDINE TRIPHOSPHATASE INHIBITORS
#4SYSTEM AND METHOD OF WAGERING ON A PLURALITY OF EVENTS
#5SUBSTITUTED PIPERIDINE DEGRONIMERS FOR TARGET PROTEIN DEGRADATION
#6N/O-LINKED DEGRONS AND DEGRONIMERS FOR PROTEIN DEGRADATION
#7CRBN LIGANDS AND USES THEREOF
#8C3-CARBON LINKED GLUTARIMIDE DEGRONIMERS FOR TARGET PROTEIN DEGRADATION
#9ESTROGEN RECEPTOR DEGRADERS, PHARMACEUTICAL COMPOSITIONS THEREOF, AND THEIR THERAPEUTIC APPLICATIONS
#10CRYSTALLINE FORMS OF A COMPOUND FOR THE TARGETED DEGRADATION OF THE ANDROGEN RECEPTOR
#11GLUTARIMIDES FOR MEDICAL TREATMENT
#12SELECTIVE HISTONE DEACETYLASE INHIBITORS FOR THE TREATMENT OF HUMAN DISEASE
#13N/O-linked degrons and degronimers for protein degradation
#14CRBN ligands and uses thereof
#15Hydantoin containing deoxyuridine triphosphatase inhibitors
#16QUATERNARY HETEROATOM CONTAINING COMPOUNDS
#17System and method of wagering on a plurality of events
#18Hydantoin containing deoxyuridine triphosphatase inhibitors
#19SELECTIVE HISTONE DEACETYLASE INHIBITORS FOR THE TREATMENT OF HUMAN DISEASE
#20Substituted piperidine Degronimers for Target Protein degradation
#21C-carbon linked glutarimide degronimers for target protein degradation
#22NOVEL COMPOUNDS HAVING BET, ESTROGEN RECEPTOR, AND ANDROGEN RECEPTOR DEGRADATION ACTIVITY AND USES THEREOF
#23N-benzyl-N-arylsulfonamide derivative and preparation and use thereof
#24Selective histone deacetylase inhibitors for the treatment of human disease
#25Piperlongumine analogues and uses thereof
#26Quaternary heteroatom containing compounds
#27CRBN ligands and uses thereof
#28Deoxyuridine triphosphatase inhibitors containing amino sulfonyl linkage
#29Deoxyuridine triphosphatase inhibitors containing cyclopropano linkage
#30Deoxyuridine triphosphatase inhibitors
#31Hydantoin containing deoxyuridine triphosphatase inhibitors
#32Glutarimides for medical treatment
#33Quaternary heteroatom containing compounds
#34N/O-linked Degrons and Degronimers for protein degradation
#35Selective histone deacetylase inhibitors for the treatment of human disease
#366-membered uracil isosteres
#37Deoxyuridine triphosphatase inhibitors
#38Method for preparing pregabalin intermediate 3-isobutylglutaric acid monoamide
#39Compositions and methods for the delivery of nucleic acids
#40C3-carbon linked glutarimide degronimers for target protein degradation
#41Compositions and methods for selectively depleting senescent cells
#42Quaternary heteroatom containing compounds
#43Deoxyuridine triphosphatase inhibitors
#44Deoxyuridine triphosphatase inhibitors containing cyclopropano linkage
#45Deoxyuridine triphosphatase inhibitors containing amino sulfonyl linkage
#46Hydantoin containing deoxyuridine triphosphatase inhibitors
#47Hydantoin containing deoxyuridine triphosphatase inhibitors
#48Deoxyuridine triphosphatase inhibitors
#49LSD1 inhibitors
#50Pharmaceutical composition comprising glutarimide derivatives and use thereof in the treatment of eosinophilic diseases
#51Asymmetrically catalyzed synthesis method of nitropyrazole amide compound
#52Intermediate for synthesizing paroxetine, method for preparing the same, and uses thereof
#53Compositions and methods for selectively depleting senescent cells
#54LSD1 inhibitors
#55Cationic lipid cordiarimide hybrid compounds and a process for preparation thereof
#56GLUCOSE METABOLISM MODULATING COMPOUNDS
#57Method for synthesizing key intermediate of apixaban
#58Pharmaceutical composition comprising glutarimide derivatives and use thereof in the treatment of eosinophilic diseases
#59UV absorbing compounds, compositions comprising same and uses thereof
#60Deoxyuridine triphosphatase inhibitors
#61SYNTHESIS OF UV ABSORBING COMPOUNDS
#62Dihydropyridin-2(1H)-one compounds as -nitrosoglutathione reductase inhibitors and neurokinin-3 receptor antagonists
#63Method for producing compounds comprising nitrile functions
#64Cycloalkane carboxylic acid derivatives as CXCR3 receptor antagonists
#65Process for producing compounds comprising nitrile functions
#66Heterocyclic compound
#67PROCESS FOR THE PREPARATION OF IMIDES AND DERIVATIVES THEREOF AND USES
#68Thionating agent
#69Process for producing compounds comprising nitrile functions
#70Thionation process and a thionating agent
#71Dihydropyridin-2(1H)-one compound as S-nirtosoglutathione reductase inhibitors and neurokinin-3 receptor antagonists
#72Quaternary heteroatom containing compounds
#73Derivatives of N-acyl-Nā²-phenylpiperazine useful (inter alia) for the prophylaxis or treatment of diabetes
#74Hypoglycemic dihydropyridones
#75Thalidomide analogs
#76Pharmaceutical compositions
#77Glucose metabolism modulating compounds
#78Heterocyclic compound
#79Preparation of diesters from imide/dinitrile compounds
#80ARYLPIPERAZINE DERIVATIVES AS ADRENERGIC RECEPTOR ANTAGONISTS
#81Piperidin-2, 6-dione pamoate salts and their use for the treatment of affective disorders
#821,2-DI(CYCLIC GROUP)SUBSTITUTED BENZENE DERIVATIVE
#83Phenylalanine derivatives
#845-phenyl-pentanoic acid derivatives as matrix metalloproteinase inhibitors for the treatment of asthma and other diseases
#85N-sulfonyldicarboximide containing tethering compounds
#86CYCLIC DERIVATIVES AS MODULATORS OF CHEMOKINE RECEPTOR ACTIVITY
#87Substituted thioacetamides
#88Processes for the synthesis of 3-isobutylglutaric acid
#89Method for the preparation of dicarboxylic lmides
#90Method for the preparation of dicarboxylic imides
#91Diaminopropionic acid derivatives
#92N-sulfonyldicarboximide containing tethering compounds
#93Cyclic derivatives as modulators of chemokine receptor activity
#94SYNTHESIS OF 4,5-DIHYDRO-PYRAZOLO[3,4-C]PYRID-2-ONES
#951,2-di(cyclic) substituted benzene derivatives
#961,2-di(cyclic) substituted benzene compounds
#97GLUTARIMIDE-CONTAINING POLYKETIDE ANALOGS AND METHODS THEREOF
#98Thalidomide analogs
#99Substituted piperidine carbamates
#100Substituted p-phenyl carbamates
#101Piperidin-2,6-dione pamoate salts and their use for the treatment of stress-related affective disorders
#102Synthesis of 4,5-dihydro-pyrazolo[3,4-c]pyrid-2-ones
#103N-sulfonyldicarboximide containing tethering compounds
#104Compounds having affinity at 5ht2C receptor and use thereof in therapy
#105Substituted thioacetamides
#106Process for the preparation of cyclic imides in the presence of polyphosphoric acid
#107N-sulfonyldicarboximide containing tethering compounds
#108Gelling agent for oil
#109Diaminopropionic acid derivatives